Emma McFarlane

2.1k total citations
40 papers, 1.2k citations indexed

About

Emma McFarlane is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Epidemiology. According to data from OpenAlex, Emma McFarlane has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 11 papers in General Health Professions and 10 papers in Epidemiology. Recurrent topics in Emma McFarlane's work include Clinical practice guidelines implementation (10 papers), Research on Leishmaniasis Studies (7 papers) and Substance Abuse Treatment and Outcomes (5 papers). Emma McFarlane is often cited by papers focused on Clinical practice guidelines implementation (10 papers), Research on Leishmaniasis Studies (7 papers) and Substance Abuse Treatment and Outcomes (5 papers). Emma McFarlane collaborates with scholars based in United Kingdom, Australia and Canada. Emma McFarlane's co-authors include Jo C Dumville, Allyson Lipp, Peggy Edwards, Alexandra Holmes, Zhenmi Liu, John C. Aust, James Alexander, Cynthia Pérez, James M. Alexander and Katharine C. Carter and has published in prestigious journals such as Cochrane Database of Systematic Reviews, The Journal of Infectious Diseases and BMJ.

In The Last Decade

Emma McFarlane

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma McFarlane United Kingdom	18	503	332	198	168	134	40	1.2k
David Martínez Hernández Spain	16	140 0.3×	139 0.4×	233 1.2×	68 0.4×	147 1.1×	37	999
Sarah S. Jackson United States	18	309 0.6×	91 0.3×	156 0.8×	48 0.3×	39 0.3×	81	1.1k
Clare Heal Australia	20	495 1.0×	238 0.7×	305 1.5×	276 1.6×	249 1.9×	100	1.4k
James C. Hebert United States	19	421 0.8×	288 0.9×	329 1.7×	66 0.4×	22 0.2×	59	1.2k
Eric Borgstein Malawi	26	295 0.6×	883 2.7×	226 1.1×	122 0.7×	20 0.1×	95	1.9k
Daniela Kroshinsky United States	26	417 0.8×	517 1.6×	493 2.5×	66 0.4×	47 0.4×	142	2.6k
Anne M. Butler United States	26	530 1.1×	136 0.4×	740 3.7×	231 1.4×	32 0.2×	77	2.0k
John Murray United States	24	324 0.6×	125 0.4×	486 2.5×	156 0.9×	166 1.2×	69	2.1k
Diana Vilar‐Compte Mexico	19	485 1.0×	72 0.2×	327 1.7×	49 0.3×	50 0.4×	86	1.4k
D. Kahn South Africa	22	860 1.7×	176 0.5×	405 2.0×	47 0.3×	26 0.2×	89	1.6k

Countries citing papers authored by Emma McFarlane

Since Specialization

Citations

This map shows the geographic impact of Emma McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma McFarlane more than expected).

Fields of papers citing papers by Emma McFarlane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma McFarlane. The network helps show where Emma McFarlane may publish in the future.

Co-authorship network of co-authors of Emma McFarlane

This figure shows the co-authorship network connecting the top 25 collaborators of Emma McFarlane. A scholar is included among the top collaborators of Emma McFarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma McFarlane. Emma McFarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mulvihill, Caroline, et al.. (2024). Recognition, diagnosis, and early management of suspected sepsis: summary of updated NICE guidance. BMJ. 385. q1173–q1173. 7 indexed citations

Chakraborty, Samantha, Tanja Kuchenmüller, John N. Lavis, et al.. (2024). Implications of living evidence syntheses in health policy. Bulletin of the World Health Organization. 102(10). 757–759.

McFarlane, Emma, et al.. (2023). Diagnosis of venous thromboembolic diseases in people with covid-19: summary of updated NICE guidance. BMJ. 383. p2204–p2204. 2 indexed citations

Navarro, David Fraile, Saskia Cheyne, Kelvin Hill, et al.. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 5: decisions on methods for evidence synthesis and recommendation development for living guidelines. Journal of Clinical Epidemiology. 155. 118–128. 15 indexed citations

Cheyne, Saskia, David Fraile Navarro, Amanda K. Buttery, et al.. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines. Journal of Clinical Epidemiology. 155. 73–83. 13 indexed citations

Sultan, Shahnaz, Rebecca L. Morgan, Philipp Dahm, et al.. (2021). An International Needs Assessment Survey of Guideline Developers Demonstrates Variability in Resources and Challenges to Collaboration between Organizations. Journal of General Internal Medicine. 37(11). 2669–2677. 5 indexed citations

McFarlane, Emma, Paul M. Kaye, Ramona Hurdayal, et al.. (2019). IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T Cells. Frontiers in Immunology. 10. 1957–1957. 9 indexed citations

García, Laura Martínez, Héctor Pardo‐Hernández, Ena Niño de Guzmán, et al.. (2017). Methodological systematic review identifies major limitations in prioritization processes for updating. Journal of Clinical Epidemiology. 86. 11–24. 24 indexed citations

Callaghan, Margaret, Karen Graham, Kirsty Loudon, et al.. (2016). What do patients and the public know about clinical practice guidelines and what do they want from them? A qualitative study. BMC Health Services Research. 16(1). 74–74. 31 indexed citations

10.

Curtis, Ashlee, et al.. (2016). Key stakeholder perspectives of drink restrictions in Newcastle, Australia. Addiction Research & Theory. 25(2). 163–167. 1 indexed citations

11.

Liira, Helena, Osmo Saarelma, Margaret Callaghan, et al.. (2015). Patients, health information, and guidelines: A focus-group study. Scandinavian Journal of Primary Health Care. 33(3). 212–219. 15 indexed citations

12.

García, Laura Martínez, Emma McFarlane, Steven J. Barnes, et al.. (2014). Updated recommendations: an assessment of NICE clinical guidelines. Implementation Science. 9(1). 72–72. 19 indexed citations

13.

Dumville, Jo C, Emma McFarlane, Peggy Edwards, Allyson Lipp, & Alexandra Holmes. (2013). Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database of Systematic Reviews. CD003949–CD003949. 257 indexed citations

14.

Miller, Peter, Darren Palmer, Nicolas Droste, et al.. (2011). Dealing with Alcohol-related problems in the Night-Time Economy: A Study Protocol for Mapping trends in harm and stakeholder views surrounding local community level interventions. BMC Research Notes. 4(1). 204–204. 15 indexed citations

15.

McFarlane, Emma, Katharine C. Carter, Andrew N. J. McKenzie, et al.. (2011). Endogenous IL-13 Plays a Crucial Role in Liver Granuloma Maturation During Leishmania donovani Infection, Independent of IL-4Rα–Responsive Macrophages and Neutrophils. The Journal of Infectious Diseases. 204(1). 36–43. 33 indexed citations

16.

Stokes, Robert J., Fiona McKenzie, Emma McFarlane, et al.. (2008). Rapid cell mapping using nanoparticles and SERRS. The Analyst. 134(1). 170–175. 16 indexed citations

17.

Alexander, James & Emma McFarlane. (2008). Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent?. Microbes and Infection. 10(9). 953–959. 12 indexed citations

18.

Henriquez, Fiona L., S. Campbell, Craig W. Roberts, et al.. (2007). DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection. Vaccine. 25(22). 4502–4509. 26 indexed citations

19.

Mullen, Alexander B., et al.. (2006). Endogenous interleukin‐18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate. Immunology. 119(3). 348–354. 14 indexed citations

20.

Carter, Katharine C., Alexander B. Mullen, Geoffrey D. Coxon, et al.. (2006). Identification of the benzodiazepines as a new class of antileishmanial agent. Bioorganic & Medicinal Chemistry Letters. 17(3). 624–627. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact